Alan D. Adams

Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator

Joel P. Berger, Ann Petro, Karen L. MacNaul et al. · Molecular Endocrinology · 2003 · 321 citations · Full text

Lipid Peroxidation, Molecular Biology, Redox Biology +17

Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype

Erik Lund, Laurence B. Peterson, Alan D. Adams et al. · Biochemical Pharmacology · 2005 · 143 citations

Molecular Pharmacology, Molecular Physiology, Biochemistry +12

A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux

Carl P. Sparrow, Joanne Baffic, My‐Hanh Lam et al. · Journal of Biological Chemistry · 2002 · 121 citations · Full text

Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation

S.M. Soisson, Gopalakrishnan Parthasarathy, Alan D. Adams et al. · Proceedings of the National Academy of Sciences · 2008 · 90 citations · Full text

Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists

Alan D. Adams, Winston Yuen, Zao Hu et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 37 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +8